🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- M96088105
- Market Cap
- Small Cap
- IPO
- 5/3/2017 · $13.00/share
Business: UroGen Pharma Ltd. is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology.
Company Contact
- CEO
- Liz Barrett
- CFO
- Chris Degnan
- Headquarters
- 400 Alexander Park Drive, Princeton, NJ 08540
- Phone
- 646-768-9780
- Investor Relations
- Vincent Perrone · 609-460-3588 · vincent.perrone@urogen.com